Subject: Chiron Venture Tests A Possible Vaccine For AIDS on Humans
Date: Published: 6/23/88 29 lines
Source:  WALL STREET JOURNAL. Copyright Dow Jones & Co. Inc. 

   Chiron Venture Tests
   A Possible Vaccine
   For AIDS on Humans

   EMERYVILLE, Calif. -- Chiron Corp. said a joint venture it
operates with Ciba-Geigy Corp. is beginning human clinical
studies on a prospective vaccine against the AIDS virus.
   Chiron said the joint venture, Biocine Co., will conduct
the tests in Geneva.  The studies are expected to last from
six months to a year, and will overlap with tests planned to
begin in the U. S. within the year, Chiron said.
   A spokeswoman said between 20 and 30 healthy males,
between the ages of 20 and 60, will be involved in the trial.
The object is to verify product safety and to see how the
prospective vaccine behaves in humans, the company said.
   Biocine was formed in April 1987 as an equally owned joint
venture of Chiron, a biotechnology concern, and Ciba-Geigy,
Ardsley, N. Y., a unit of Ciba-Geigy AG, a Swiss-based
pharmaceutical and chemical manufacturer.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]